Reduced proliferation and invasion has been described in melanoma after knockdown of Rab27a (Akavia et al., 2010; Guo et al., 2019), while in breast cancer cell growth was decreased (Bobrie et al., 2012). Here, RAB27A is linked to breast carcinoma.